DexCom, Inc. (DXCM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for DexCom, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 30.97x | 54.61x | 88.46x | 129.24x | 239.45x | 70.71x |
| P/B Ratio | 9.43x | 14.97x | 23.16x | 20.68x | 25.43x | 19.11x |
| P/S Ratio | 5.56x | 7.80x | 13.22x | 15.15x | 21.21x | 18.11x |
| Profitability | ||||||
| Gross Margin | 60.0% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 8.9% | 25.6% |
| EBITDA Margin | 25.0% | 23.4% | 25.3% | 19.4% | 15.4% | 19.6% |
| Liquidity | ||||||
| Current Ratio | 1.88x | 1.47x | 2.84x | 1.99x | 5.11x | 5.58x |
| Quick Ratio | 1.59x | 1.28x | 2.48x | 1.83x | 4.62x | 5.19x |
| Leverage | ||||||
| Debt/Equity | 0.51x | 1.23x | 1.25x | 1.01x | 1.06x | 1.01x |
YoY = year-over-year change. Source: FMP..